125742 S2 M3 32s4 validation analyt procedure overview

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

1

Document text

BNT162b2
3.2.S.4.3 Validation of Analytical Procedures
Overvie w
PFIZER CONFIDENTIAL
Page 13.2.S.4.3. OVERVIEW
Validation of anal ytical procedures was performed to ensure the composition, strength, 
identity , purity , and safety  of BNT162b2 drug substance .  All non- compendial and 
compendial anal ytical procedures were confirmed suitable for their intended use. 
090177e19700b47a\Approved\Approved On: 12-May-2021 07:48 (GMT)
(b) (4)
FDA-CBER-2021-5683-1149294